Skip to main content

UBS Group AG

Position in CING — Cingulate Inc.

CIK 1610520 ZURICH, V8

Position in CING

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$68,514
-$51,634 QoQ
Shares Held
11,033
-60.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CING Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $7,583,514,316 across 563 Biotechnology names. CING ranks #360 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CING

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $68,514 11,033
2025-12-31 $120,148 27,684
2025-09-30 $5,088 1,298
2025-06-30 $51,465 12,645
2025-03-31 $95,098 22,116
2024-12-31 $60,126 12,196
2024-09-30 $69,294 13,749
2023-09-30 $99 140
2023-03-31 $829 842
2022-12-31 $6,717 6,717
2022-09-30 $16,132 15,077
2021-12-31 $13,016 4,716